Sage Journals: Discover world-class research

Abstract

Objective:

Bladder cancer is the commonest cancer of the urinary tract. Transurethral Resection of Bladder Tumour (TURBT) is the gold standard for diagnosis and treatment of non-muscle invasive bladder cancer. The absence of muscle in a TURBT specimen is associated with a significantly higher risk of residual disease, early recurrence and tumour under staging.

Materials and methods:

TURBT and bladder biopsy specimens were examined before and after the introduction of an open reporting system as a quality improvement exercise. All specimens from the 4th quarter (between 2010 and 2014) were examined to determine the effect of open reporting on our inadequate resection rates.

Results:

A total of 244 cases were performed under the care of 5 consultant urologists. Analysis revealed a significant improvement in quality of both T1 and Ta resections (p=0.04*; p=0.02*) after the introduction of open reporting. The total number of TURBT cases increased per year, however the percentage of inadequate resections has significantly decreased (p=0.02*).

Conclusion:

Individual reporting provided surgeons with direct, personal and timely feedback on their performance. It did not negatively impact on trainee participation, but led to improved training outcomes. We have demonstrated that our simple intervention has improved quality of patient care.

Keywords

Urinary bladder neoplasms TURBT quality improvement safety culture incident reporting

Get full access to this article

View all access options for this article.

References

Avritscher

Cooksley

Grossman

. Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology 2006; 68: 549–553.

Cancer Research UK. Bladder cancer incidence statistics. 2014. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bladder-cancer/incidence (accessed 23 March 2016).

Persad

Lamm

Brausi

. Current approaches to the management of non-muscle invasive bladder cancer: comparison of current guidelines and recommendations. Eur Urology Suppl 2008; 7: 637–650.

London Cancer Alliance. LCA urological cancers guidelines October 2014. London Cancer Alliance, London, UK, 2014.

Brausi

Collette

Kurth

. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002; 41: 523–531.

Mariappan

Zachou

Grigor

; Edinburgh Uro-Oncology Group. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 2010; 57: 843–849.

Herr

Donat

. Quality control in transurethral resection of bladder tumours. BJU Int 2008; 102: 1242–1246.

Grimm

Steinhoff

Simon

. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003; 170: 433–437.

Divrik

Yildirim

Zorlu

. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumours of the bladder who received intravesical mitomycin: prospective, randomized clinical trial. J Urol 2006; 175: 1641–1644.

10.

Jahnson

Wiklund

Duchek

. Results of second-look resection after primary resection of T1 tumour of the urinary bladder. Scand J Urol Nephrol 2005; 39: 206–210.

11.

Lazica

Roth

Brandt

. Second transurethral resection after Ta high-grade bladder tumor: a 4.5-year period at a single university center. Urol Int 2014; 92: 131–135.

12.

Vasdev

Dominguez-Escrig

Paez

. The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer. Ecancermedicalscience 2012; 6: 269.

13.

Babjuk

Bohle

Burger

. Guidelines on non-muscle invasive bladder cancer (Ta, T1 and CIS). European Association of Urology, 2015.

14.

Carthey

Clarke

. The ‘how to guide’ for implementing human factors in healthcare. London: Patient Safety First, 2010.

15.

Leape

Berwick

Clancy

. Transforming healthcare: a safety imperative. Qual Saf Health Care 2009; 18: 424–428.

16.

Haynes

Weiser

Berry

. Changes in safety attitude and relationship to decreased postoperative morbidity and mortality following implementation of a checklist-based surgical safety intervention. BMJ Qual Saf 2011; 20: 102–107.

17.

Hofmann

Mark

. An investigation of the relationship between safety climate and medication errors as well as other urse and patient outcomes. Personnel Psychol 2006; 59: 847–869.

18.

Mardon

Khanna

Sorra

. Exploring relationships between hospital patient safety culture and adverse events. J Patient Saf 2010; 6: 226–232.

19.

DiCuccio

. The relationship between patient safety culture and patient outcomes: a systematic review. J Patient Saf 2015; 11: 135–142.

20.

Mark

Hughes

Belyea

. Exploring organizational context and structure as predictors of medication errors and patient falls. J Patient Saf 2008; 4: 66–77.

21.

The Health Foundation. Evidence scan: Does improving safety culture affect patient outcomes? 2011. http://www.health.org.uk/publication/does-improving-safety-culture-affect-patient-outcomes (accessed 23 March 2016).

22.

Vincent

Taylor-Adams

Stanhope

. Framework for analysing risk and safety in clinical medicine. BMJ 1998; 316: 1154–1157.

23.